ABSTRACT The endogenous central nervous tissue substance called MLC (morphine-like compound) is shown to bind to the opiate receptors of the mouse neuroblastoma x glioma hybrid cell line NG108-15. The interaction of MLC with these opiate receptors is noncooperative, as is the interaction of morphine, naloxone, and Leu-enkephalin with these receptors. A specific antibody to morphine will bind MLC but will not bind P-endorphin, Leu-enkephalin, or Met-enkephalin. It would appear, therefore, that MLC can be considered to be a different type of endogenous ligand for the opiate receptor. We have previously reported that specific antibodies against morphine can be used to identify the existence of an endogenous morphine-like compound (MLC) in the central nervous system of many species of vertebrates (1). MLC has been shown to be morphine-like on the basis of its immunological activity, its chromatographic mobility, and its biological activity on the guinea pig ileum and mouse vas deferens (1). MLC appears to be quite different from any of the endogenous opiate peptides (i.e., enkephalins and endorphins) (2-9) because MLC is resistant to peptidase activity and to acid treatment (1).
naloxone HCI from Endo Labs, Garden City, NY; and morphine sulfate from Hoffmann-La Roche, Nutley, NJ.
Cells. The mouse neuroblastoma X rat glioma hybrid clone NG108-15 (10) was used and was kindly supplied by Marshall Nirenberg, National Heart and Lung Institute, National Institutes of Health, Bethesda, MD. Cells were grown in Dulbecco's modified Eagle's medium plus 10% horse serum, penicillin G (10 units/ml), streptomycin sulfate (10,ug/ml), 0.1 mM hypoxanthine, 1 M aminopterin, and 12 ,uM thymidine. Cells were used at passages 19-45 after reaching 50-100% confluency.
Binding Assays. (Intact cells) Cells were shaken off flasks and washed three times with 0.32 M sucrose/10 mM Tris-HCl pH 8.0/0.5 mM CaCl2. Washed pellets were resuspended in 0.32 M sucrose/10 mM Tris-HCl/0.5 mM CaCl2/1 mM dithiothreitol. Cells were kept at 40 until they were used. Binding of 3H-labeled optiates to intact cells was determined according to the method of Klee and Nirenberg (10) with the following modifications. Final reaction volume was 0.5 ml and contained 0.2 to 0.5 X 106 cells, 0.32 M sucrose, 10 mM Tris-HCl at pH 8.0, and, as noted in the text, 0.5 mM MgCl2, 0.5 mM CaCl2, and 1 mM dithiothreitol. Reactions were initiated by addition of cells and then the tubes were placed in a shaking water bath (370) for 5 min. Reactions were terminated by centrifugation, either for 5 min in a Brinkmann Eppendorf microcentrifuge (model 3200) or for 10 min at 30,000 X g in a Sorvall centrifuge. The supernatant was aspirated and the tubes were carefully rinsed with 1 ml of 0.32 M sucrose/10 mM Tris-HCI, pH 8.0. The washed pellets were then suspended in 1 ml of 1% Triton X-100 and transferred to counting vials containing 10 ml of Aquasol (New England Nuclear). All assays were performed in triplicate and the results given are the mean; values differed by less than 10%.
(Cell membranes) Cells were shaken off and washed once. in buffer (50 mM Tris-HCl, pH 7.4). Washed pellets were resuspended in buffer, homogenized (twice for 10 sec) in a Brinkmann Polytron (model PT 1020 350D) at 40, and then spun at 27,000 X g for 30 min at 4°. Pellets were resuspended in buffer and respun, and the washed pellets were finally resuspended in buffer so as to give 0.2-1 mg of protein per ml. Membranes were kept at 40 until use. Reaction tubes contained 400 ml of the membrane suspension and various concentrations of radioactive and nonradioactive ligands. The final reaction volume was 0.5 ml and the final concentration of Tris-HCI at pH 7.4 was 50 mM. Reactions were initiated by the addition of membranes and the tubes were then placed in a shaking water bath (370) for 10 min. Reactions were terminated by the addition of 4 ml of 50 mM Tris-HCI at pH 7.4 (40), followed by rapid filtration over Whatman GF/B filters. The tubes and (10, 13, 14) had shown that the opiate receptors of these cells can bind a variety of opiates and opiate antagonists. In agreement with their findings, we observed that the specific binding of [3H]Leu-enkephalin was completely inhibited by nonradioactive naloxone and morphine as well as by Leuenkephalin. Inhibition curves for all three nonradioactive ligands occurred over two orders of magnitude and had a Hill coefficient of one. We have converted the concentrations of naloxone, morphine, and Leu-enkephalin that gave 50% inhibition of the specific binding of [3H]Leu-enkephalin to their corresponding Ki values ( Table 1 ). The affinity of Leu-enkephalin for the opiate receptors of these cells as measured by inhibition (Ki = 6 nM) was in close agreement with that measured by direct binding (Kd = 5 nM). The affinity of Leuenkephalin was found to be about 6 and 16 times stronger than the affinities of naloxone and morphine, respectively.
Having established some of the binding properties of the opiates Leu-enkephalin, morphine, and the opiate antagonist naloxone, we investigated whether MLC would also inhibit the specific binding of [3H]Leu-enkephalin (Fig. 2) . We observed that increasing amounts of MLC caused larger and larger in- (Fig. 3) . As was seen for morphine, naloxone, and Leu-enkephalin, the Hill coefficient for MLC inhibition was always one, regardless of which 3H-labeled ligand was used (Fig. 3) (Fig. 4) 
